Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meletios-Athanassios Dimopoulos

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 2, 2013
Ovarian malignant ascites-derived lymphocytes stimulated with prothymosin α or its immunoactive decapeptide lyse autologous tumour cells in vitro and retard tumour growth in SCID miceIoannis F Voutsas, Nikolaos Pistamaltzian, Marinos L Tsiatas, et al.
Anticancer Research|March 6, 2014
Low protein expression of MET in ER-positive and HER2-positive breast cancerFlora Zagouri, Anita Brandstetter, Dimitrios Moussiolis, et al.
Obstetrics and Gynecology|July 2, 2013
Breast cancer in women aged 25 years and youngerConstantine Dimitrakakis, Alexandra Tsigginou, Flora Zagouri, et al.
Oncotargets and Therapy|June 20, 2019
Evaluation of MET T1010I and MET rs40239 single-nucleotide polymorphisms in triple-negative breast cancer: a case-control studyDespoina Kalapanida, Flora Zagouri, Maria Gazouli, et al.
MDM Policy & Practice|February 8, 2019
Development of an Initial Conceptual Model of Multiple Myeloma to Support Clinical and Health Economics Decision MakingSebastian Gonzalez-McQuire, Meletios-Athanassios Dimopoulos, Katja Weisel, et al.
Breast Care (Basel, Switzerland)|January 14, 2014
Does pregnancy-associated breast cancer imply a worse prognosis? A matched case-case studyConstantine Dimitrakakis, Flora Zagouri, Alexandra Tsigginou, et al.
British Journal of Haematology|November 17, 2006
Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myelomaEvangelos Terpos, Deborah J Heath, Amin Rahemtulla, et al.
Molecular Biology Reports|May 11, 2013
MMP-2 -1306C>T polymorphism in breast cancer: a case-control study in a South European populationFlora Zagouri, Theodoros N Sergentanis, Maria Gazouli, et al.
Journal of Clinical Medicine|September 10, 2021
Bone Marrow Microenvironment Interplay and Current Clinical Practice in Multiple Myeloma: A Review of the Balkan Myeloma Study GroupJelena Bila, Eirini Katodritou, Margarita Guenova, et al.
Clinical Breast Cancer|January 22, 2016
Safety and Tolerability of Anthracycline-Containing Adjuvant Chemotherapy in Elderly High-Risk Breast Cancer PatientsVasilios Karavasilis, Christos Papadimitriou, Helen Gogas, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|January 2, 2013
Ovarian malignant ascites-derived lymphocytes stimulated with prothymosin α or its immunoactive decapeptide lyse autologous tumour cells in vitro and retard tumour growth in SCID miceIoannis F Voutsas, Nikolaos Pistamaltzian, Marinos L Tsiatas, et al.
Anticancer Research|March 6, 2014
Low protein expression of MET in ER-positive and HER2-positive breast cancerFlora Zagouri, Anita Brandstetter, Dimitrios Moussiolis, et al.
Obstetrics and Gynecology|July 2, 2013
Breast cancer in women aged 25 years and youngerConstantine Dimitrakakis, Alexandra Tsigginou, Flora Zagouri, et al.
Oncotargets and Therapy|June 20, 2019
Evaluation of MET T1010I and MET rs40239 single-nucleotide polymorphisms in triple-negative breast cancer: a case-control studyDespoina Kalapanida, Flora Zagouri, Maria Gazouli, et al.
MDM Policy & Practice|February 8, 2019
Development of an Initial Conceptual Model of Multiple Myeloma to Support Clinical and Health Economics Decision MakingSebastian Gonzalez-McQuire, Meletios-Athanassios Dimopoulos, Katja Weisel, et al.
Breast Care (Basel, Switzerland)|January 14, 2014
Does pregnancy-associated breast cancer imply a worse prognosis? A matched case-case studyConstantine Dimitrakakis, Flora Zagouri, Alexandra Tsigginou, et al.
British Journal of Haematology|November 17, 2006
Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myelomaEvangelos Terpos, Deborah J Heath, Amin Rahemtulla, et al.
Molecular Biology Reports|May 11, 2013
MMP-2 -1306C>T polymorphism in breast cancer: a case-control study in a South European populationFlora Zagouri, Theodoros N Sergentanis, Maria Gazouli, et al.
Journal of Clinical Medicine|September 10, 2021
Bone Marrow Microenvironment Interplay and Current Clinical Practice in Multiple Myeloma: A Review of the Balkan Myeloma Study GroupJelena Bila, Eirini Katodritou, Margarita Guenova, et al.
Clinical Breast Cancer|January 22, 2016
Safety and Tolerability of Anthracycline-Containing Adjuvant Chemotherapy in Elderly High-Risk Breast Cancer PatientsVasilios Karavasilis, Christos Papadimitriou, Helen Gogas, et al.
Pageof 6